Genetic factors in Alzheimer's disease: A review of recent advances

Annals of Neurology

Volumn 40, Issue 6, 1996, Pages 829-840

  Levy Lahad, Ephrat ^a   Bird, Thomas D ^b,c,d  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b Rehabilitation Care Services S 117   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AMYLOID NEUROPATHY; AUTOSOMAL DOMINANT INHERITANCE; DOWN SYNDROME; ETHNIC GROUP; FAMILIAL DISEASE; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; GENETIC COUNSELING; HUMAN; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; ETHNIC GROUPS; HUMANS; MEMBRANE PROTEINS; MUTATION; PRESENILIN-1;

EID: 0030483182     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400604     Document Type: Review

References (147)

1. Larson EB, Kukull WA, Katzman RL. Cognitive impairment, dementia and Alzheimer's disease. Annu Rev Public Health 1992;13:431-439
2. Hofman A, Rocca WA, Brayne C, et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int J Epidemiol 1991;20:736-748
3. Hirst C, Yee IML, Sadovnick AD. Familial risk for Alzheimer disease from a population based series. Genet Epidemiol 1994;11:365-374
4. Hocking LB, Breitner JCS. Cumulative risk of Alzheimer-like dementia in relatives of autopsy-confirmed cases of Alzheimer's disease. Dementia 1995;6:355-356
5. Bierer L, Silverman J, Mohs R, et al. Morbid risk to first degree relatives of neuropathologically confirmed cases of Alzheimer's disease. Dementia 1992;3:134-139
6. Farrar L, Cupples LA, van Duijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for risk of dementia among relatives. Ann Neurol 1995;38: 797-808
7. Mohs R, Breitner J, Silverman J, et al. Alzheimer's disease - morbid risk among first degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry 1987;44:405-408
8. Mann DMA. Association between Alzheimer's disease and Down syndrome: neuropathological observations. In: Berg JM, Karlinsky J, Holland AJ, eds. Alzheimer disease, Down syndrome, and their relationship. Oxford: Oxford University Press, 1993:71-92
9. Cook RH, Ward BE, Austin JH. Studies in aging of the brain: IV. Familial Alzheimer disease: relation to transmissible dementia, aneuploidy, and microtubular defects. Neurology 1979;29:1402-1412
10. Nee LE, Polinsky RJ, Eldridge R, et al. A family with histologically confirmed Alzheimer's disease. Arch Neurol 1983; 40:203-208
11. Foncin JF, Salmon D, Supino-Viterbo V, et al. Demence Presenile D'Alzheimer transmise dans une famille étundue. Rev Neurol (Paris) 1985;141:194-202
12. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;24:12-25
13. Goudsmit JAAP, White BJ, Weitkamp LR, et al. Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin. J Neurol Sci 1981;49:79-89
14. Martin JHJ, Bruyland M, Cras P, et al. Early-onset Alzheimer's disease in 2 large Belgian families. Neurology 1991;41: 62-68
15. Goate AM, Chartier-Harlene CM, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;353:844-846
16. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760
17. Levy-Lahad E, Wasco W, Poorkaj P, et al. A candidate for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977
18. Stritmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E; high avidity binding to beta amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
19. Corder EH, Saunders AM, Stritmatter WJ, et al. Gene dose of the apolipoprotein E type-4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923
20. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-736
21. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120:885-890
22. Lemaire HG, Salbaum JM, Multhaup G, et al. The preA4 695 precursor protein of Alzheimer's disease A4 amyloid in encoded by 16 exons. Nucleic Acids Res 1989;17:517-522
23. Tanzi RE, Gusella JF, Watkins PC, et al. Amyloid-protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987;235:880-884
24. Rumble B, Retallak R, Hilbich C, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989;320:1446-1452
25. Naruse S, Igarashi S, Aoki K, et al. Mis-sense mutation Val Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 1991;337:978-979
26. Karlinsky H, Vaula G, Haines JL, et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β-amyloid precursor protein gene. Neurology 1992;42: 1445-1453
27. Fidani L, Rooke K, Chartier-Harlin M, et al. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP 717 Val Ile. Hum Mol Genet 1992;1:165-168
28. Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with presenile dementia. Science 1991;254:94-99
29. Chartier-Harlin CM, Crawford F, Houlden H, et al. Early-onset Alzheimer's disease caused by a mutation in codon717 of the beta-amyloid precursor protein gene. Nature 1991;353: 844-846
30. Mullan M, Crawford H, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992;1:345-347
31. Hendriks L, Van Duijn C, Crass P, et al. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992; 1:218-221
32. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-1126
33. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987;235:885-890
34. St. George-Hyslop PH, Haines JL, Farrar LA, et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 1990;347:194-197
35. Schellenberg GD, Bird TD, Wijsman EM, et al. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science 1988;241:1507-1510
36. Pericak-Vance MA, Yamaoka LH, Haynes CS, et al. Genetic linkage studies in Alzheimer's disease families. Exp Neurol 1988;102:271-279
37. Kamino K, Orr TH, Payami H, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992;51:998-1014
38. Evenhuis HM. The natural history of dementia in Down's syndrome. Arch Neurol 1990;47:263-276
39. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995;373:523-527
40. Hsiao KK, Borchelt DR, Olson K, et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 1995; 145:1203-1218
41. Higgins LS, Rodems JM, Catalano R, et al. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proc Natl Acad Sci 1995;92: 4402-4406
42. Sisodia SS, Koo EH, Beyruther K, et al. Evidence that β amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990;248:492-495
43. Haass C, Scholssmacher MG, Hung AY, et al. Amyloid beta peptide is produced by cultured cell during normal metabolism. Nature 1992;359:322-325
44. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantitation of soluble Alzheimer's beta peptide from biological fluids. Nature 1992;359:325-327
45. Cai XD, Golde TE, Younkin SG. Release of excess beta-amyloid beta protein from a mutant amyloid beta protein precursor. Science 1993;259:514-516
46. Citron M, Oltersdorf T, Haass C, et al. Mutation of the beta amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992;360:672-674
47. Haass C, Hung AY, Selkoe DJ, Teplow DB. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 1994;269:1-8
48. Citron M, Vego-Pelfrey C, Teplow DB, et al. Excessive production of amyloid beta protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc Natl Acad Sci USA 1994;91:11993-11997
49. Suzuki N, Cheung TT, Cai XD, et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (APP717) mutants. Science 1994;264: 1336-1340
50. Tamaoka A, Odaka A, Ishibashi Y, et al. APP 717 missense mutation affects the ratio of amyloid beta protein species in familial Alzheimer's disease brain. J Biol Chem 1994;269: 32721-32724
51. Jarrett JT, Lansbury PT Jr. Seeding 'one dimensional crystallisation' of amyloid: a pathogenic mechanism in Alzheimer disease and scrapie? Cell 1993;73:1055-1058
52. Yamatsuji T, Matsui T, Okamoto T, et al. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 1996;272: 1349-1352
53. Schellenberg CO, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671
54. St. George-Hyslop P, Haines J, Rogaev E, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992;2:330-334
55. Van Broeckhoven C, Backhovens H, Cruts M, et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 1992;2:335-339
56. Mullan M, Houlden H, Windelspecht M, et al. A locus for familial early-onset Alzheimer's disease maps to the long arm of chromosome 14, proximal to the alpha1-antichymotrypsin gene. Nat Genet 1992;2:340-342
57. Alzheimer's Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995;11:219-222
58. Sahara A, Yahagi Y, Hideyuki T, et al. Identification and characterization of presenilin I-467, I-463 and I-374. FEBS Lett 1996;381:7-11
59. Rogaev EI, Sherrington R, Rogaeva E, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromsome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778
60. Chapman J, Asherov A, Wang N, et al. Familial Alzheimer's disease associated with S182 codon 286 mutation. Lancet 1996;346:1040
61. Campion D, Flaman J-M, Brice A. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995;4:2373-2377
62. Cervenakova L, Brown P, Kenney K. Identification of AD3 gene point mutations in three early-onset Alzheimer's disease families. Neurology 1995;46:A249
63. Sorbi S, Nacmias B, Forleo P, et al. Missense mutation of S182 in Italian families with early-onset Alzheimer's disease. Lancet 1996;346:439-440
64. Tanahashi H, Mitsunaga Y, Takahashi K, et al. Missense mutation of S182 gene in Japanese familial Alzheimer's disease. Lancet 1995;346:440
65. Wasco W, Pettingel WP, Jondro PD, et al. Familial Alzheimer's disease chromosome 14 mutations. Nat Med 1995;1: 848
66. Perez-Tur J, Froelich S, Prihar G, et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 1995;7:297-301
67. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994;36:368-378
68. Bird TD, Lampe TH, Nemens EJ, et al. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 1988;23:25-31
69. Bird TD, Nemens EM, Nochlin D, et al. Familial Alzheimer's disease in Germans from Russia: a model of genetic heterogeneity in Alzheimer's disease. In: Boller F, et al, eds. Heterogeneity of Alzheimer's Disease. Berlin: Springer-Verlag, 1992: 118-129
70. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269:970-973
71. Levy-Lahad E, Wang K, Mulligan J, et al. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer's disease gene. Genomics (in press)
72. Bird TD, Levy-Lahad E, Poorkaj P, et al. Wide range in age-of-onset tor chromosome 1 related familial Alzheimer's disease. Ann Neurol 1996;40:932-935
73. Schellenberg G, Payami H, Wijsman E, et al. Chromosome 14 and late onset familial Alzheimer's disease. Am J Hum Genet 1993;53:619-628
74. Wragg M, Hutton M, Talbot G, the Alzheimer's Disease Collaborative Group. Genetic association between intronic polymorphism in the presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512
75. Keho P, Williams J, Lovestone S, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1185-1186
76. Higuchi S, Muramatsu T, Matsushita S, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347: 1186
77. Scott WK, Growdon JH, Roses AD, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1186-1187
78. Kovacs DM, Fausett HJ, Page KJ, et al. Alzheimer-associated presinilins 1 and 2: neuronal expression in the brain and localization to intracellular membranes in mammalian cells. Nat Med 1996;2:224-229
79. Levitan D, Greenwald I. Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995;377:351-354
80. L'Hernault SW, Arduengo PM. Mutation of a putative sperm membrane protein in Caenorhabtidis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 1995;119:55-68
81. Scheuner D, Eckman C, Jensen M, et al. The amyloid β protein deposited in the senile plaques or Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996; 2:864-870
82. Smale G, Nichols NR, Brady DR, et al. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133: 225-230
83. Loo DT, Copani CJ, Pike ER. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993;99:7951-7955
84. Busciglio J, Yankner B. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995;378:776-779
85. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca+2 binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996;271:521-525
86. Bird TD, Bennett RL. Why do DNA testing? Practical and ethical implications of new neurogenetic tests. Ann Neurol 1995;38:141-146
87. Lannfelt L, Axelman K, Lilius L, Basun H. Genetic counseling in a Swedish Alzheimer family with amyloid precursor protein mutation. Am J Hum Genet 1995;56:332-335
88. Pericak-Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;41:1034-1050
89. Schellenberg GD, Deeb SS, Boehnke M, et al. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet 1987;4:97-108
90. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res 1991;641:163-166
91. Saunders AM, Stritmatter WJ, Schmechel D, et al. Association of the apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
92. Yu CE, Payami H, Olson JM, et al. The apolipoprotein E/ CI/CII gene cluster and late-onset Alzheimer's disease. Am J Hum Genet 1994;54:631-642
93. Rebeck GW, Reitet JS, Stirckland DK. Apolipoprotein E in sporadic Alzheimer's disease: allelic variations and receptor interactions. Neuron 1993;11:575-580
94. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein e4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
95. Tsai MS, Tsangalos EG, Petersen RC. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54: 643-649
96. Van Duijn CM, de Kniff P, Cruts M, et al. Apolipoprotein e4 allele in a population based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78
97. Perez-Tur J, Campion D, Martinez M, et al. Evidence for apolipoprotein e4 association in early-onset Alzheimer's patients with late-onset relatives. Am J Med Genet 1995;60: 550-553
98. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphisms and Alzheimer's disease. Lancet 1993;342: 697-699
99. Corder EH, Saunders AM, Risch NJ. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184
100. Lucotte G, Aouzirate A, Gerard N, et al. Allele doses of apolipoprotein E type e4 in sporadic late-onset Alzheimer's disease. Am J Med Genet 1995;60:566-569
101. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E e4 and gender. JAMA 1994;271:1316-1317
102. Farret LA, Cupples LA, van Duijn CM. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995;38: 797-808
103. Tsuda T, Lopez R, Rogaeva EA, et al. Are the associations between Alzheimer's disease and the polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? Ann Neurol 1994;36:97-100
104. Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with ApoE e2. Lancet 1994;343:1432-1433
105. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259
106. Tang MX, Maestre G, Tsai W-Y, et al. Relative risk of Alzheimer's disease and age-at-onset distributions, based on ApoE genotypes among elderly African Americans, Caucasians and Hispanics in New York City. Am J Hum Genet 1996;58: 574-584
107. van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E e2 allele is associated with an increased risk of early onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610
108. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 1994;177:100-102
109. Noguchi S, Murakami K, Nobuhiro Y. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;324:737
110. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-120
111. St. George-Hyslop P, McLachlan DC, Tuda T, et al. Alzheimer's disease and possible gene interaction. Science 1994;263: 537
112. Alzheimer's Disease Collaborative Group. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:738-739
113. Nacmias B, Latorraca S, Piersanti P, et al. ApoE genotype and familial Alzheimer's disease: a possible influence on age-of-onset in APP Val → 12 Ile mutated families. Neurosci Lett 1995;183:1-3
114. Sorbi S, Nacmias B, Forleo P, et al. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995;38:124-127
115. Brooks WS, Martins RN, De Voecht J, et al. A mutation in codon 717 of the amyloid precursor gene in an Australian family with Alzheimer's disease. Neurosci Lett 1995;199:183-186
116. Haan J, Van Broeckhoven C, van Duijn CM, et al. The apolipoprotein E e4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 and 692 mutation. Ann Neurol 1994;36:434-437
117. Van Broeckhoven C, Backhovens H, Cruts M, et al. ApoE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994;169:179-180
118. Levy-Lahad E, Lahad A, Wijsman EM, et al. Apolipoprotein E genotypes and early-onset familial Alzheimer's disease. Ann Neurol 1995;38:679-680
119. van Gool WA, Evenhuis HM, van Duijn CM, for the Dutch Study Group on Down's Syndrome and Aging. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann Neurol 1995;38:225-230
120. Schupf, Kappel D, Zigman W, et al. Dementia and decline in adaptive competence is associated with ApoE ε4 in Down's syndrome. Neurology 1996;46:A419
121. Jarvik GP, Larson EB, Goddard K, et al. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 1996;58: 191-200
122. Jarvik GP, Wijsman EM, Kukul WA, et al. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 1995;45:1092-1096
123. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease. Statement on use of apolipoprotein E testing for Alzheimer's disease. JAMA 1995;274:1627-1629
124. Breitner JCS. ApoE genotyping and Alzheimer's disease. Lancet 1996;347:1184
125. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein allele e4 is overrepresented in patients with Lewy body variant of Alzheimer's disease. Neurology 1994;44:950-951
126. Schneider JA, Gearing M, Robbins RS, et al. Apolipoprotein E genotyping in diverse neurodegenerative disorders. Ann Neurol 1995;38:131-135
127. Frisoni GB, Bianchetti A, Govoni S. Association of apolipoprotein E e4 with vascular dementia. JAMA 1994;271:1317
128. Isoe K, Urakami K, Sato K, et al. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996;93:133-137
129. Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995;38: 317-318
130. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancer 1996;347:1091-1095
131. Roses RD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14
132. Saunders AM, Hulette C, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-93
133. Poirier J, Delisle M-C, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995; 92:12260-12264
134. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N Engl J Med 1996;334:759-762
135. Schmechel DE, Saunders AM, Strimatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of ApoE genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-9653
136. Strittmatter WJ, Saunders AM, Schmechel D, et al. Binding of human apolipoprotein E to β A4 peptide: isoform specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:8098-8102
137. Sana DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoE3. J Clin Invest 1994;94:860-869
138. LaDu MJ, Falduto MT, Manelli AM, et al. Isoform specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994; 269:23403-23406
139. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437
140. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 1994;91:11183-11186
141. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E e4 in Alzheimer's disease. Ann Neurol 1996;39:62-70
142. Poirier J. Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurosci 1994;17:525-530
143. 42(43). Ann Neurol 1996;40:49-156
144. Mann DMA, Iwatsubo T, Nochlin D, et al. Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: the Volga German families. Ann Neurol 1996;40:208-213
145. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 1996;274:99-102
146. Thinakaran G, Borchelt DR, Lee MK, et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 1996;17:181-190
147. Duff K, Eckman C, Zehr C, et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996;383:710-713